Page last updated: 2024-08-16

procyclidine and scopolamine hydrobromide

procyclidine has been researched along with scopolamine hydrobromide in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19903 (25.00)18.7374
1990's1 (8.33)18.2507
2000's4 (33.33)29.6817
2010's4 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Lombardo, F; Obach, RS; Waters, NJ1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Delgado, JM; Glaser, GH; Vas, CJ1
Heise, GA; Keller, C; Laughlin, N1
Maickel, RP1
Danielson, ND; Holeman, JA1
Aas, P; Enger, S; Myhrer, T2
Aas, P; Andersen, JM; Myhrer, T; Nguyen, NH1
Joosen, MJ; Kuijpers, WC; Noort, D; van der Schans, MJ; van Helden, HP1

Reviews

2 review(s) available for procyclidine and scopolamine hydrobromide

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Timing of decontamination and treatment in case of percutaneous VX poisoning: a mini review.
    Chemico-biological interactions, 2013, Mar-25, Volume: 203, Issue:1

    Topics: Acetylcholinesterase; Animals; Butyrylcholinesterase; Chemical Warfare Agents; Cholinesterase Inhibitors; Decontamination; Disease Models, Animal; Guinea Pigs; Organophosphate Poisoning; Organothiophosphorus Compounds; Procyclidine; Pyridostigmine Bromide; Scopolamine; Skin; Time Factors

2013

Other Studies

10 other study(ies) available for procyclidine and scopolamine hydrobromide

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Effects of anticholinergic drugs on epileptic activity from amygdala and frontal cortex. A comparative study in monkeys.
    Neurology, 1969, Volume: 19, Issue:3

    Topics: Amygdala; Animals; Behavior, Animal; Cerebral Cortex; Electric Stimulation; Electroencephalography; Haplorhini; Parasympatholytics; Procyclidine; Scopolamine

1969
A behavioral and pharmacological analysis of reinforcement withdrawal.
    Psychopharmacologia, 1970, Volume: 16, Issue:5

    Topics: Animals; Atropine; Carbachol; Chlordiazepoxide; Chlorpromazine; Dextroamphetamine; Male; Neostigmine; Pentobarbital; Phenobarbital; Procyclidine; Rats; Reinforcement Schedule; Reinforcement, Psychology; Scopolamine; Sound

1970
Diverse central effects of chlorpromazine.
    International journal of neuropharmacology, 1968, Volume: 7, Issue:1

    Topics: Animals; Atropine; Behavior, Animal; Brain; Brain Chemistry; Chlorpromazine; Cholinesterase Inhibitors; Depression, Chemical; Dextroamphetamine; Injections, Intraperitoneal; Male; Motor Activity; Procyclidine; Rats; Scopolamine

1968
Microbore liquid chromatography of tertiary amine anticholinergic pharmaceuticals with tris(2,2'-bipyridine)ruthenium(III) chemiluminescence detection.
    Journal of chromatographic science, 1995, Volume: 33, Issue:6

    Topics: 2,2'-Dipyridyl; Amines; Amitriptyline; Atropine; Butanones; Cholinergic Antagonists; Chromatography, High Pressure Liquid; Cyclopentolate; Dicyclomine; Hydrogen-Ion Concentration; Indicators and Reagents; Luminescent Measurements; Organometallic Compounds; Procyclidine; Scopolamine

1995
Cognitive side effects in rats caused by pharmacological agents used to prevent soman-induced lethality.
    European journal of pharmacology, 2004, Jan-12, Volume: 483, Issue:2-3

    Topics: Animals; Cognition Disorders; Drug Therapy, Combination; Exploratory Behavior; Lethal Dose 50; Male; Physostigmine; Procyclidine; Rats; Rats, Wistar; Scopolamine; Soman

2004
Protection against soman-induced seizures in rats: relationship among doses of prophylactics, soman, and adjuncts.
    Toxicology and applied pharmacology, 2004, May-01, Volume: 196, Issue:3

    Topics: Animals; Cholinesterase Inhibitors; Convulsants; Dizocilpine Maleate; Dose-Response Relationship, Drug; Electroencephalography; Hippocampus; Male; Muscarinic Antagonists; Neuroprotective Agents; Physostigmine; Procyclidine; Rats; Rats, Wistar; Scopolamine; Seizures; Soman

2004
Roles of perirhinal and posterior piriform cortices in control and generation of seizures: a microinfusion study in rats exposed to soman.
    Neurotoxicology, 2010, Volume: 31, Issue:1

    Topics: Animals; Anticonvulsants; Cerebral Cortex; Disease Models, Animal; Electroencephalography; GABA Agonists; Male; Muscarinic Antagonists; Muscimol; Procyclidine; Quinoxalines; Rats; Rats, Wistar; Scopolamine; Seizures; Soman; Statistics, Nonparametric

2010